Biotech Acquisition Co
NASDAQ:BIOT
Income Statement
Earnings Waterfall
Biotech Acquisition Co
Revenue
|
0
USD
|
Operating Expenses
|
-3.7m
USD
|
Operating Income
|
-3.7m
USD
|
Other Expenses
|
11.8m
USD
|
Net Income
|
8m
USD
|
Income Statement
Biotech Acquisition Co
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||
Operating Expenses |
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
|
Other Operating Expenses |
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
|
Operating Income |
(1)
N/A
|
(1)
-101%
|
(2)
-27%
|
(3)
-111%
|
(4)
-24%
|
(4)
+9%
|
|
Pre-Tax Income | |||||||
Interest Income Expense |
3
|
3
|
3
|
0
|
0
|
1
|
|
Total Other Income |
(5)
|
(2)
|
(9)
|
(1)
|
14
|
10
|
|
Pre-Tax Income |
(3)
N/A
|
0
N/A
|
(7)
N/A
|
(5)
+31%
|
10
N/A
|
8
-17%
|
|
Net Income | |||||||
Income from Continuing Operations |
(3)
|
0
|
(7)
|
(5)
|
10
|
8
|
|
Net Income (Common) |
(3)
N/A
|
0
N/A
|
(7)
N/A
|
(5)
+31%
|
10
N/A
|
8
-17%
|
|
EPS (Diluted) |
-0.09
N/A
|
0.01
N/A
|
-0.25
N/A
|
-0.16
+36%
|
0.34
N/A
|
0.28
-18%
|